# Cabergoline

NDC: 70512-860
Generic name: cabergoline
Labeler / Manufacturer: SOLA Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230508

FDA application: ANDA076310

## Active ingredients

- CABERGOLINE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70512-860"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70512-860
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=275a6a25-c3c9-4258-a610-0b00752517f7